Skip to content

Peripheral Perfusion Index-guided Fluid Resuscitation for Preventing Acute Skin Failure in Elderly Critically Ill Patients

Effect of Peripheral Perfusion Index-guided Fluid Resuscitation on the Prevention of Acute Skin Failure in Elderly Critically Ill Patients: A Prospective, Randomized, Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07367113
Acronym
PPI-PROTECT
Enrollment
216
Registered
2026-01-26
Start date
2025-01-01
Completion date
2026-12-01
Last updated
2026-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Skin Failure, Sepsis, Septic Shock

Brief summary

This prospective, randomized, controlled trial aimed to evaluate whether fluid resuscitation guided by the Peripheral Perfusion Index (PPI) could reduce the incidence of Acute Skin Failure (ASF) in elderly critically ill patients. A total of 216 patients aged ≥65 years with sepsis or other types of shock requiring early aggressive fluid resuscitation were enrolled and randomly assigned in a 1:1 ratio to either the PPI-guided resuscitation group or the conventional resuscitation group. The intervention group targeted maintaining PPI ≥1.4 in addition to conventional hemodynamic goals, while the control group followed standard resuscitation protocols. The primary outcome was the incidence of ASF within 7 days of ICU admission, diagnosed according to NPUAP/EPUAP (2014) criteria. Secondary outcomes included time to ASF occurrence, lactate clearance, cumulative fluid balance, organ function, and long-term prognosis.

Interventions

OTHERPeripheral Perfusion Index-guided Fluid Resuscitation Protocol

In addition to achieving conventional macro-hemodynamic goals (mean arterial pressure ≥65 mmHg, etc.), a resuscitation protocol targeting a Peripheral Perfusion Index (PPI) value ≥1.4 is implemented. PPI is continuously monitored via a finger pulse oximeter. If PPI remains below 1.4 for \>30 minutes, a fluid responsiveness assessment (e.g., passive leg raising test) is performed. Fluid boluses (balanced crystalloid) are administered only if the patient is fluid-responsive. Otherwise, vasoactive agents are optimized.

OTHERConventional Goal-Directed Fluid Resuscitation

Fluid resuscitation is performed according to the Surviving Sepsis Campaign International Guidelines. Resuscitation targets include: mean arterial pressure ≥65 mmHg, central venous pressure 8-12 mmHg, urine output ≥0.5 mL·kg-¹·h-¹, and normalization/decreasing trend of serum lactate. The type, rate, and volume of fluid administration are determined by the treating physician based on these standard macro-hemodynamic and perfusion parameters.

Sponsors

Ying Wang
Lead SponsorOTHER
Nantong First People's Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 65 years. 2. Diagnosis of sepsis (according to Sepsis-3 criteria) or other types of shock requiring early and aggressive fluid resuscitation. 3. APACHE II score ≥ 15 at ICU admission. 4. Expected ICU length of stay ≥ 72 hours. 5. Written informed consent obtained from the patient or their legally authorized representative.

Exclusion criteria

1. Pre-existing stage III or higher pressure injury or skin necrosis at the time of enrollment. 2. Severe dermatological disease or peripheral vascular disease that could interfere with the assessment of skin or peripheral perfusion. 3. Inability to perform continuous finger pulse oximetry monitoring (e.g., due to bilateral finger injury, amputation, or severe peripheral edema). 4. Contraindications to liberal fluid resuscitation (e.g., acute cardiogenic pulmonary edema, severe heart failure with fluid overload). 5. Expected survival \< 24 hours due to terminal illness or irreversible condition. Concurrent participation in another interventional clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Acute Skin Failure(per the NPUAP/EPUAP 2014 Guidelines)From ICU admission up to 7 daysProportion of patients who develop new-onset Acute Skin Failure (ASF) within 7 days after ICU admission. ASF is diagnosed and staged according to the NPUAP/EPUAP (2014) criteria.

Secondary

MeasureTime frameDescription
Time to Acute Skin Failure (ASF) OnsetFrom ICU admission up to 7 daysNumber of days from ICU admission to the first diagnosis of ASF (assessed in patients who develop ASF)
Maximum Stage of Acute Skin FailureFrom ICU admission up to 7 daysThe most severe stage of ASF (according to NPUAP/EPUAP 2014 criteria) observed within 7 days after ICU admission
Lactate Clearance Rate at 6 HoursBaseline and 6 hours after resuscitation initiationPercentage decrease in serum lactate concentration from baseline to 6 hours after initiation of resuscitation
Lactate Clearance Rate at 24 HoursBaseline and 24 hours after resuscitation initiationPercentage decrease in serum lactate concentration from baseline to 24 hours after initiation of resuscitation
Cumulative Fluid Balance at 72 HoursFrom ICU admission up to 72 hoursNet fluid balance (total fluid intake minus total output) calculated over the first 72 hours of ICU stay
Incidence of Acute Kidney InjuryFrom ICU admission up to 7 daysProportion of patients who develop AKI according to KDIGO criteria within 7 days after ICU admission
Duration of Mechanical VentilationFrom ICU admission until ICU discharge, up to 90 daysTotal number of days requiring invasive mechanical ventilation during ICU stay
Length of ICU StayFrom ICU admission until ICU discharge, up to 90 daysTotal number of days from ICU admission to ICU discharge
28-Day All-Cause MortalityFrom ICU admission up to 28 daysProportion of patients who die from any cause within 28 days after ICU admission
90-Day All-Cause MortalityFrom ICU admission up to 90 daysProportion of patients who die from any cause within 90 days after ICU admission
Barthel Index at Hospital DischargeAt hospital discharge, up to 90 days after ICU admissionScore of the Barthel Index (a measure of activities of daily living) assessed at the time of hospital discharge in surviving patients. Range: 0-100, higher scores indicate greater independence
Total Hospitalization CostsFrom hospital admission to hospital discharge, up to 90 daysTotal direct medical costs incurred during the index hospitalization, expressed in local currency
30-Day Unplanned Readmission Rate30 days after hospital dischargeProportion of patients who have an unplanned readmission to any hospital within 30 days after hospital discharge
Incidence of Resuscitation-Related Serious Adverse EventsFrom ICU admission until ICU discharge, up to 90 daysProportion of patients who experience serious adverse events related to fluid resuscitation (e.g., new-onset cardiogenic pulmonary edema, arrhythmia requiring intervention) during the ICU stay

Countries

China

Contacts

CONTACTYing Wang
wenquxingdiyi@163.com+86 13485139816

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 10, 2026